Cinryze is Efficacious for Hereditary Angioedema (HAE) Attack Prevention In Pediatric Patients: Final Phase 3 Efficacy And Safety Results
Gespeichert in:
| Autor*in: |
Aygören-Pürsün, Emel [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2018 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Antidiabetic treatment in elderly patients with low performance status admitted to internal medicine ward - Papakitsou, I. ELSEVIER, 2022, official publication of the American Academy of Allergy, Asthma and Immunology, Amsterdam [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:141 ; year:2018 ; number:2 ; pages:46 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.jaci.2017.12.151 |
|---|
| Katalog-ID: |
ELV041941047 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV041941047 | ||
| 003 | DE-627 | ||
| 005 | 20230624092633.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180726s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jaci.2017.12.151 |2 doi | |
| 028 | 5 | 2 | |a GBV00000000000134A.pica |
| 035 | |a (DE-627)ELV041941047 | ||
| 035 | |a (ELSEVIER)S0091-6749(17)32051-1 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 610 | |
| 082 | 0 | 4 | |a 610 |q DE-600 |
| 082 | 0 | 4 | |a 610 |q VZ |
| 084 | |a 44.85 |2 bkl | ||
| 100 | 1 | |a Aygören-Pürsün, Emel |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Cinryze is Efficacious for Hereditary Angioedema (HAE) Attack Prevention In Pediatric Patients: Final Phase 3 Efficacy And Safety Results |
| 264 | 1 | |c 2018 | |
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 700 | 1 | |a Soteres, Daniel F. |4 oth | |
| 700 | 1 | |a Nieto–Martinez, Sandra |4 oth | |
| 700 | 1 | |a Christensen, Jim |4 oth | |
| 700 | 1 | |a Jacobson, Kraig W. |4 oth | |
| 700 | 1 | |a Moldovan, Dumitru |4 oth | |
| 700 | 1 | |a Van Leerberghe, Arthur |4 oth | |
| 700 | 1 | |a Tang, Tom |4 oth | |
| 700 | 1 | |a Lu, Peng |4 oth | |
| 700 | 1 | |a Martinez-Saguer, Inmaculada |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier |a Papakitsou, I. ELSEVIER |t Antidiabetic treatment in elderly patients with low performance status admitted to internal medicine ward |d 2022 |d official publication of the American Academy of Allergy, Asthma and Immunology |g Amsterdam [u.a.] |w (DE-627)ELV000021164 |
| 773 | 1 | 8 | |g volume:141 |g year:2018 |g number:2 |g pages:46 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.jaci.2017.12.151 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | b | k | |a 44.85 |j Kardiologie |j Angiologie |q VZ |
| 951 | |a AR | ||
| 952 | |d 141 |j 2018 |e 2 |h 46 |y 141.2018, 2, AB46- | ||
| 953 | |2 045F |a 610 | ||
| author_variant |
e a p eap |
|---|---|
| matchkey_str |
aygrenprsnemelsoteresdanielfnietomartine:2018----:irziefccosohrdtragodmhetakrvninneitiptetfnl |
| hierarchy_sort_str |
2018 |
| bklnumber |
44.85 |
| publishDate |
2018 |
| allfields |
10.1016/j.jaci.2017.12.151 doi GBV00000000000134A.pica (DE-627)ELV041941047 (ELSEVIER)S0091-6749(17)32051-1 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 44.85 bkl Aygören-Pürsün, Emel verfasserin aut Cinryze is Efficacious for Hereditary Angioedema (HAE) Attack Prevention In Pediatric Patients: Final Phase 3 Efficacy And Safety Results 2018 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Soteres, Daniel F. oth Nieto–Martinez, Sandra oth Christensen, Jim oth Jacobson, Kraig W. oth Moldovan, Dumitru oth Van Leerberghe, Arthur oth Tang, Tom oth Lu, Peng oth Martinez-Saguer, Inmaculada oth Enthalten in Elsevier Papakitsou, I. ELSEVIER Antidiabetic treatment in elderly patients with low performance status admitted to internal medicine ward 2022 official publication of the American Academy of Allergy, Asthma and Immunology Amsterdam [u.a.] (DE-627)ELV000021164 volume:141 year:2018 number:2 pages:46 https://doi.org/10.1016/j.jaci.2017.12.151 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.85 Kardiologie Angiologie VZ AR 141 2018 2 46 141.2018, 2, AB46- 045F 610 |
| spelling |
10.1016/j.jaci.2017.12.151 doi GBV00000000000134A.pica (DE-627)ELV041941047 (ELSEVIER)S0091-6749(17)32051-1 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 44.85 bkl Aygören-Pürsün, Emel verfasserin aut Cinryze is Efficacious for Hereditary Angioedema (HAE) Attack Prevention In Pediatric Patients: Final Phase 3 Efficacy And Safety Results 2018 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Soteres, Daniel F. oth Nieto–Martinez, Sandra oth Christensen, Jim oth Jacobson, Kraig W. oth Moldovan, Dumitru oth Van Leerberghe, Arthur oth Tang, Tom oth Lu, Peng oth Martinez-Saguer, Inmaculada oth Enthalten in Elsevier Papakitsou, I. ELSEVIER Antidiabetic treatment in elderly patients with low performance status admitted to internal medicine ward 2022 official publication of the American Academy of Allergy, Asthma and Immunology Amsterdam [u.a.] (DE-627)ELV000021164 volume:141 year:2018 number:2 pages:46 https://doi.org/10.1016/j.jaci.2017.12.151 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.85 Kardiologie Angiologie VZ AR 141 2018 2 46 141.2018, 2, AB46- 045F 610 |
| allfields_unstemmed |
10.1016/j.jaci.2017.12.151 doi GBV00000000000134A.pica (DE-627)ELV041941047 (ELSEVIER)S0091-6749(17)32051-1 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 44.85 bkl Aygören-Pürsün, Emel verfasserin aut Cinryze is Efficacious for Hereditary Angioedema (HAE) Attack Prevention In Pediatric Patients: Final Phase 3 Efficacy And Safety Results 2018 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Soteres, Daniel F. oth Nieto–Martinez, Sandra oth Christensen, Jim oth Jacobson, Kraig W. oth Moldovan, Dumitru oth Van Leerberghe, Arthur oth Tang, Tom oth Lu, Peng oth Martinez-Saguer, Inmaculada oth Enthalten in Elsevier Papakitsou, I. ELSEVIER Antidiabetic treatment in elderly patients with low performance status admitted to internal medicine ward 2022 official publication of the American Academy of Allergy, Asthma and Immunology Amsterdam [u.a.] (DE-627)ELV000021164 volume:141 year:2018 number:2 pages:46 https://doi.org/10.1016/j.jaci.2017.12.151 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.85 Kardiologie Angiologie VZ AR 141 2018 2 46 141.2018, 2, AB46- 045F 610 |
| allfieldsGer |
10.1016/j.jaci.2017.12.151 doi GBV00000000000134A.pica (DE-627)ELV041941047 (ELSEVIER)S0091-6749(17)32051-1 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 44.85 bkl Aygören-Pürsün, Emel verfasserin aut Cinryze is Efficacious for Hereditary Angioedema (HAE) Attack Prevention In Pediatric Patients: Final Phase 3 Efficacy And Safety Results 2018 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Soteres, Daniel F. oth Nieto–Martinez, Sandra oth Christensen, Jim oth Jacobson, Kraig W. oth Moldovan, Dumitru oth Van Leerberghe, Arthur oth Tang, Tom oth Lu, Peng oth Martinez-Saguer, Inmaculada oth Enthalten in Elsevier Papakitsou, I. ELSEVIER Antidiabetic treatment in elderly patients with low performance status admitted to internal medicine ward 2022 official publication of the American Academy of Allergy, Asthma and Immunology Amsterdam [u.a.] (DE-627)ELV000021164 volume:141 year:2018 number:2 pages:46 https://doi.org/10.1016/j.jaci.2017.12.151 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.85 Kardiologie Angiologie VZ AR 141 2018 2 46 141.2018, 2, AB46- 045F 610 |
| allfieldsSound |
10.1016/j.jaci.2017.12.151 doi GBV00000000000134A.pica (DE-627)ELV041941047 (ELSEVIER)S0091-6749(17)32051-1 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 44.85 bkl Aygören-Pürsün, Emel verfasserin aut Cinryze is Efficacious for Hereditary Angioedema (HAE) Attack Prevention In Pediatric Patients: Final Phase 3 Efficacy And Safety Results 2018 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Soteres, Daniel F. oth Nieto–Martinez, Sandra oth Christensen, Jim oth Jacobson, Kraig W. oth Moldovan, Dumitru oth Van Leerberghe, Arthur oth Tang, Tom oth Lu, Peng oth Martinez-Saguer, Inmaculada oth Enthalten in Elsevier Papakitsou, I. ELSEVIER Antidiabetic treatment in elderly patients with low performance status admitted to internal medicine ward 2022 official publication of the American Academy of Allergy, Asthma and Immunology Amsterdam [u.a.] (DE-627)ELV000021164 volume:141 year:2018 number:2 pages:46 https://doi.org/10.1016/j.jaci.2017.12.151 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.85 Kardiologie Angiologie VZ AR 141 2018 2 46 141.2018, 2, AB46- 045F 610 |
| language |
English |
| source |
Enthalten in Antidiabetic treatment in elderly patients with low performance status admitted to internal medicine ward Amsterdam [u.a.] volume:141 year:2018 number:2 pages:46 |
| sourceStr |
Enthalten in Antidiabetic treatment in elderly patients with low performance status admitted to internal medicine ward Amsterdam [u.a.] volume:141 year:2018 number:2 pages:46 |
| format_phy_str_mv |
Article |
| bklname |
Kardiologie Angiologie |
| institution |
findex.gbv.de |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
Antidiabetic treatment in elderly patients with low performance status admitted to internal medicine ward |
| authorswithroles_txt_mv |
Aygören-Pürsün, Emel @@aut@@ Soteres, Daniel F. @@oth@@ Nieto–Martinez, Sandra @@oth@@ Christensen, Jim @@oth@@ Jacobson, Kraig W. @@oth@@ Moldovan, Dumitru @@oth@@ Van Leerberghe, Arthur @@oth@@ Tang, Tom @@oth@@ Lu, Peng @@oth@@ Martinez-Saguer, Inmaculada @@oth@@ |
| publishDateDaySort_date |
2018-01-01T00:00:00Z |
| hierarchy_top_id |
ELV000021164 |
| dewey-sort |
3610 |
| id |
ELV041941047 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV041941047</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624092633.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180726s2018 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.jaci.2017.12.151</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000134A.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV041941047</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0091-6749(17)32051-1</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.85</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Aygören-Pürsün, Emel</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Cinryze is Efficacious for Hereditary Angioedema (HAE) Attack Prevention In Pediatric Patients: Final Phase 3 Efficacy And Safety Results</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2018</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Soteres, Daniel F.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nieto–Martinez, Sandra</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Christensen, Jim</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Jacobson, Kraig W.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Moldovan, Dumitru</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Van Leerberghe, Arthur</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tang, Tom</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lu, Peng</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Martinez-Saguer, Inmaculada</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Papakitsou, I. ELSEVIER</subfield><subfield code="t">Antidiabetic treatment in elderly patients with low performance status admitted to internal medicine ward</subfield><subfield code="d">2022</subfield><subfield code="d">official publication of the American Academy of Allergy, Asthma and Immunology</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV000021164</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:141</subfield><subfield code="g">year:2018</subfield><subfield code="g">number:2</subfield><subfield code="g">pages:46</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.jaci.2017.12.151</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.85</subfield><subfield code="j">Kardiologie</subfield><subfield code="j">Angiologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">141</subfield><subfield code="j">2018</subfield><subfield code="e">2</subfield><subfield code="h">46</subfield><subfield code="y">141.2018, 2, AB46-</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| author |
Aygören-Pürsün, Emel |
| spellingShingle |
Aygören-Pürsün, Emel ddc 610 bkl 44.85 Cinryze is Efficacious for Hereditary Angioedema (HAE) Attack Prevention In Pediatric Patients: Final Phase 3 Efficacy And Safety Results |
| authorStr |
Aygören-Pürsün, Emel |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV000021164 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 610 DE-600 610 VZ 44.85 bkl Cinryze is Efficacious for Hereditary Angioedema (HAE) Attack Prevention In Pediatric Patients: Final Phase 3 Efficacy And Safety Results |
| topic |
ddc 610 bkl 44.85 |
| topic_unstemmed |
ddc 610 bkl 44.85 |
| topic_browse |
ddc 610 bkl 44.85 |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
d f s df dfs s n sn j c jc k w j kw kwj d m dm l a v la lav t t tt p l pl i m s ims |
| hierarchy_parent_title |
Antidiabetic treatment in elderly patients with low performance status admitted to internal medicine ward |
| hierarchy_parent_id |
ELV000021164 |
| dewey-tens |
610 - Medicine & health |
| hierarchy_top_title |
Antidiabetic treatment in elderly patients with low performance status admitted to internal medicine ward |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV000021164 |
| title |
Cinryze is Efficacious for Hereditary Angioedema (HAE) Attack Prevention In Pediatric Patients: Final Phase 3 Efficacy And Safety Results |
| ctrlnum |
(DE-627)ELV041941047 (ELSEVIER)S0091-6749(17)32051-1 |
| title_full |
Cinryze is Efficacious for Hereditary Angioedema (HAE) Attack Prevention In Pediatric Patients: Final Phase 3 Efficacy And Safety Results |
| author_sort |
Aygören-Pürsün, Emel |
| journal |
Antidiabetic treatment in elderly patients with low performance status admitted to internal medicine ward |
| journalStr |
Antidiabetic treatment in elderly patients with low performance status admitted to internal medicine ward |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology |
| recordtype |
marc |
| publishDateSort |
2018 |
| contenttype_str_mv |
zzz |
| container_start_page |
46 |
| author_browse |
Aygören-Pürsün, Emel |
| container_volume |
141 |
| class |
610 610 DE-600 610 VZ 44.85 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Aygören-Pürsün, Emel |
| doi_str_mv |
10.1016/j.jaci.2017.12.151 |
| dewey-full |
610 |
| title_sort |
cinryze is efficacious for hereditary angioedema (hae) attack prevention in pediatric patients: final phase 3 efficacy and safety results |
| title_auth |
Cinryze is Efficacious for Hereditary Angioedema (HAE) Attack Prevention In Pediatric Patients: Final Phase 3 Efficacy And Safety Results |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA |
| container_issue |
2 |
| title_short |
Cinryze is Efficacious for Hereditary Angioedema (HAE) Attack Prevention In Pediatric Patients: Final Phase 3 Efficacy And Safety Results |
| url |
https://doi.org/10.1016/j.jaci.2017.12.151 |
| remote_bool |
true |
| author2 |
Soteres, Daniel F. Nieto–Martinez, Sandra Christensen, Jim Jacobson, Kraig W. Moldovan, Dumitru Van Leerberghe, Arthur Tang, Tom Lu, Peng Martinez-Saguer, Inmaculada |
| author2Str |
Soteres, Daniel F. Nieto–Martinez, Sandra Christensen, Jim Jacobson, Kraig W. Moldovan, Dumitru Van Leerberghe, Arthur Tang, Tom Lu, Peng Martinez-Saguer, Inmaculada |
| ppnlink |
ELV000021164 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth oth oth oth |
| doi_str |
10.1016/j.jaci.2017.12.151 |
| up_date |
2024-07-06T21:28:22.003Z |
| _version_ |
1803866658050146304 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV041941047</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624092633.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180726s2018 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.jaci.2017.12.151</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000134A.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV041941047</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0091-6749(17)32051-1</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.85</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Aygören-Pürsün, Emel</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Cinryze is Efficacious for Hereditary Angioedema (HAE) Attack Prevention In Pediatric Patients: Final Phase 3 Efficacy And Safety Results</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2018</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Soteres, Daniel F.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nieto–Martinez, Sandra</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Christensen, Jim</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Jacobson, Kraig W.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Moldovan, Dumitru</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Van Leerberghe, Arthur</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tang, Tom</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lu, Peng</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Martinez-Saguer, Inmaculada</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Papakitsou, I. ELSEVIER</subfield><subfield code="t">Antidiabetic treatment in elderly patients with low performance status admitted to internal medicine ward</subfield><subfield code="d">2022</subfield><subfield code="d">official publication of the American Academy of Allergy, Asthma and Immunology</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV000021164</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:141</subfield><subfield code="g">year:2018</subfield><subfield code="g">number:2</subfield><subfield code="g">pages:46</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.jaci.2017.12.151</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.85</subfield><subfield code="j">Kardiologie</subfield><subfield code="j">Angiologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">141</subfield><subfield code="j">2018</subfield><subfield code="e">2</subfield><subfield code="h">46</subfield><subfield code="y">141.2018, 2, AB46-</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| score |
7.403097 |